November 17th, 2026Real-World Data Support Cemiplimab Efficacy in Advanced NSCLCIn this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.Read more
November 12th, 2026Oral Enlicitide Could Close Primary Prevention Gap: Christie Ballantyne, MDIn this Q&A, Christie Ballantyne, MD, explains why consistent LDL-C lowering with oral enlicitide could expand PCSK9 use in primary prevention.Read more
November 18th, 2026Low CRC Incidence Found After Endoscopic Mucosal ResectionCRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.Read more
November 17th, 2026Precision Medicine Equity Hinges on Systems, but Coverage Gaps Linger Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics. Read more
November 14th, 2026ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's CostsResearch at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.Read more
November 18th, 2026IgA Nephropathy, FSGS Care Needs Coordinators, Not Just New DrugsSan Francisco experts say earlier IgA nephropathy and FSGS detection depends on primary care education and care coordinators.Read more
November 18th, 2026Obstructive HCM Care Hinges on Teams, Pharmacy, and Drug Access Cardiologists and pharmacy leaders explained how team-based clinics and standardized paperwork are speeding obstructive HCM treatment.Read more
November 18th, 2026FDA Approves Secukinumab as First Anti–IL-17 Biologic for PMRThe FDA has approved secukinumab for PMR after the REPLENISH trial showed doubled sustained remission and lower steroid use vs a steroid taper alone.Read more